CA
GILD icon

CGN Advisors’s Gilead Sciences GILD Stock Holding History

CGN Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Buy
25,722
+272
+1% +$35.8K 0.24% 82
2026
Q1 		$3.55M Sell
25,450
-342
-1% -$47.9K 0.28% 69
2025
Q4 		$3.17M Sell
25,792
-1,103
-4% -$134K 0.25% 80
2025
Q3 		$2.99M Buy
26,895
+351
+1% +$39.9K 0.25% 86
2025
Q2 		$2.94M Buy
26,544
+373
+1% +$39.7K 0.26% 83
2025
Q1 		$2.93M Sell
26,171
-4,785
-15% -$494K 0.29% 80
2024
Q4 		$2.86M Sell
30,956
-759
-2% -$68.3K 0.28% 82
2024
Q3 		$2.66M Buy
31,715
+4,656
+17% +$355K 0.27% 93
2024
Q2 		$1.86M Buy
27,059
+24,186
+842% +$1.61M 0.22% 117
2024
Q1 		$210K Sell
2,873
-3,142
-52% -$242K 0.03% 246
2023
Q4 		$487K Sell
6,015
-26,462
-81% -$2.06M 0.07% 180
2023
Q3 		$2.43M Buy
32,477
+892
+3% +$68.6K 0.33% 84
2023
Q2 		$2.43M Buy
31,585
+4,187
+15% +$334K 0.35% 78
2023
Q1 		$2.27M Buy
27,398
+2,014
+8% +$167K 0.36% 76
2022
Q4 		$2.18M Buy
25,384
+7,650
+43% +$606K 0.38% 70
2022
Q3 		$1.09M Buy
17,734
+3,823
+27% +$241K 0.27% 100
2022
Q2 		$860K Buy
13,911
+4,450
+47% +$276K 0.24% 103
2022
Q1 		$562K Buy
9,461
+2,049
+28% +$131K 0.14% 140
2021
Q4 		$538K Buy
7,412
+278
+4% +$19.1K 0.14% 140
2021
Q3 		$498K Buy
7,134
+568
+9% +$39.9K 0.16% 132
2021
Q2 		$452K Buy
6,566
+198
+3% +$13.2K 0.14% 140
2021
Q1 		$412K Buy
6,368
+522
+9% +$33.7K 0.15% 133
2020
Q4 		$341K Buy
+5,846
New +$353K 0.14% 141

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CGN Advisors's GILD Position: Q2 2026 in Review

CGN Advisors increased its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, buying an estimated $35.8K and bringing the position to 25,722 shares worth $3.25M. The position accounts for 0.24% of the portfolio, ranked #82.

CGN Advisors first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.55M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CGN Advisors held 25,722 shares of Gilead Sciences worth $3.25M as of Q2 2026.
  • CGN Advisors bought 272 Gilead Sciences shares in Q2 2026, an estimated $35.8K.
  • Gilead Sciences made up 0.24% of CGN Advisors's portfolio in Q2 2026, its #82 holding.
  • CGN Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • CGN Advisors's Gilead Sciences position peaked at $3.55M in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.